Controlling the Cost Spent on Expensive Biologic Agents: an Example of Net Monetary Savings By Dose Optimisation of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Patients

Authors :: Kievit, W.
Herwaarden, N. van
Hoogen, F. van den
Vollenhoven, R. van
Bijlsma, H.
Bemt, B.J. van den
Maas, A. van der
Broeder, A. den
Kievit, W.
Herwaarden, N. van
Hoogen, F. van den
Vollenhoven, R. van
Bijlsma, H.
Bemt, B.J. van den
Maas, A. van der
Broeder, A. den
Source :: Value in Health; A647; A648; 1098-3015; 7; 18; ~Value in Health~A647~A648~~~1098-3015~7~18~~
Publication Year :: 2015
Abstract: Contains fulltext : 152071.pdf (publisher's version ) (Closed access)

Database :: OAIster
Journal :: Value in Health; A647; A648; 1098-3015; 7; 18; ~Value in Health~A647~A648~~~1098-3015~7~18~~
Publication Type :: Electronic Resource
Accession number :: edsoai.on1284155637
Document Type :: Electronic Resource

Tools